The Checkup by Singlecare

JANUARY 9, 2025

Compounded versions of semaglutide contain varying ingredients, and theyre not approved by the U.S. Food and Drug Administration (FDA). Its often easier and cheaper to obtain compounded semaglutide products compared to brand-name medications, but pharmacists and healthcare professionals warn that these products can come with risks.

Compounding 104

Compounding Compounding Pharmacies FDA Sterile Compounds 104

DiversifyRx

APRIL 29, 2025

Should You Keep Compounding GLP1s (Tirzepatide or Semaglutide) After the FDA Deadline? Howdy pharmacy peeps… Lets have a real talk about compounding GLP1s. These compounds have been huge revenue drivers and powerful tools for helping patients lose weight and improve metabolic health. Here’s My Take.

Compounding 52

Compounding Sterile Compounds FDA Compounding Pharmacies 52

Pharmacy Times

JULY 18, 2025

Rumore, PharmD, Esq, MS, LLM, FAPhA Key Takeaways The removal of tirzepatide and semaglutide from the FDA's shortage list impacts 503A compounders, requiring adherence to complex legal and regulatory frameworks. SHOW MORE GLP-1 compounding faces legal challenges, evolving FDA rules, and heightened enforcement risks.

Compounding 73

Compounding Compounding Pharmacies Documentation FDA 73

Omnicell

SEPTEMBER 5, 2022

Unfortunately, many formularies for RTA products are limited by personalized dosing requirements, especially among the pediatric population and increasingly with the demand for DNA-informed tailored dosing. His was a leading voice in persuading the FDA to require bar codes on all immediate drug containers.

Compounding 52

Compounding Sterile Compounds Documentation Omnicell 52